Interestingly, PPARγ agonism has been shown to alter cancer derived EV-miRNAs (16), but it is not known whether pioglitazone treatment in people with T2D exerts any pharmacologic effect via regulation of AT-derived EV-miRNAs. The gene discussed is PPARG; the disease is cancer.